AclarusDx Logo (WIPO, 08/24/2010)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark AclarusDx was filed as Figurative mark on 08/24/2010 at the World Intellectual Property Organization.
Logodesign (Wiener Klassifikation)
#Letters presenting a special form of writing #Colours #Letters overlapping #Two predominant colours
| Trademark form | Figurative mark |
| File reference | 1063526 |
| Countries | 
|
| Base trademark |
No. 10 3 761 324,
August 20, 2010
|
| Application date | August 24, 2010 |
| Expiration date | August 24, 2020 |
Trademark owner
63-65 boulevard Masséna
F-75013 PARIS
FR
F-75013 PARIS
FR
Trademark representatives
78 avenue Raymond Poincaré
F-75116 PARIS
FR
goods and services
01
Chemical preparations and compositions, namely nucleic acids
attached to a solid medium intended for industry and
science; fissile chemical elements; chemicals for analyses,
other than for medical or veterinary purposes; biological
preparations, other than for medical or veterinary purposes,
namely biological preparations enabling the quantification
of nucleic acid content; chemicals for scientific use, other
than for medical or veterinary purposes; chemical
preparations or reagents for laboratory analyses, other than
for medical or veterinary purposes; preparations for
diagnosis, other than for medical or veterinary purposes
05
Pharmaceutical preparations for treating neurodegenerative
diseases, particularly Alzheimer's disease; tests, namely
tests based on blood biomarkers enabling the identification
of patients suffering from Alzheimer's disease or at risk of
developing the disease and enabling the identification of
patients responding to specific treatments; acidic
biological preparations and products for pharmaceutical
purposes, namely pharmaceutical preparations for diagnosing
Alzheimer's disease; capsules for diagnostic tests and
medicines; chemico-pharmaceutical preparations for
diagnosing, preventing and treating Alzheimer's disease;
biopharmaceutical preparations for diagnosing, preventing
and treating Alzheimer's disease; chemicals for medical,
pharmaceutical or veterinary purposes, especially for
diagnosing neurodegenerative diseases, especially
Alzheimer's disease; products for medical and clinical
diagnosis, namely probes and kits for medical and clinical
diagnosis, comprising nucleic acid banks, nucleic acids on
DNA chips; DNA libraries, particularly for decoding the
genes affected by Alzheimer's disease or revealing the
transcriptomic signature of patients suffering from
Alzheimer's disease; DNA chips containing DNA for decoding
the genes affected by Alzheimer's disease or revealing the
transcriptomic signature of patients suffering from
Alzheimer's disease; chips, namely DNA chips, with the aim
of making visible and analyzing gene expression in the
fields of human medicine, pharmacology and veterinary
sciences; enzymes or enzyme preparations for medical or
veterinary purposes, namely enzyme stabilizers, enzyme
substrates used as ingredients in medicines for Alzheimer's
disease; reagents (contained in kits for taking blood
samples) required for the preservation of the biological
material under analysis in order to carry out the test under
the appropriate conditions
10
Surgical, medical, dental and veterinary apparatus and
instruments, particularly for identifying, assessing the
seriousness of, assessing prognoses of, measuring the
progression of and measuring the conversion of diseases;
medical devices using DNA chips for analyzing blood;
apparatus for analyzing blood; apparatus using DNA chips for
diagnosis, for medical purposes, namely DNA chips for
diagnosing Alzheimer's disease, namely materials for taking
blood (contained in kits for taking blood samples) required
for the preservation of the biological material under
analysis in order to carry out the test under the
appropriate conditions; spoons for medicines; containers for
the application of medicines; probes for medical purposes;
syringes for medical purposes; galvanic therapeutic
appliances, particularly for diagnosing neurodegenerative
diseases, especially Alzheimer's disease
42
Research and development, for others, of pharmaceutical
molecules or biological markers and medicines for diagnosing
and treating neurodegenerative diseases; chemical analyses;
chemical research; chemical services, namely analysis of RNA
genes, tissues, and blood samples; biotechnological project
studies, particularly to enable the identification of people
suffering from Alzheimer's disease and to measure the
seriousness, prognoses, progression and conversion of the
disease and to determine how patients respond to treatments;
research and development of new products for others;
biological research; biotechnological research; technical
research in the field of biotechnology; biotechnological
analysis services; laboratory analyses, namely
quantification of nucleic acid content
44
Medical services; veterinary services; medical assistance;
consulting in the fields of biotechnology and pharmacy,
namely to assist in the selection of Alzheimer's sufferers
for clinical trials and to offer personalized treatments;
hospitals; pharmaceutical industry and pharmacist (preparing
prescriptions) services, namely geriatric and neurological
services in order to facilitate diagnoses and care; health
care; telemedicine services
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| August 27, 2021 | 2021/34 Gaz | Deletion | |
| September 2, 2015 | 2015/37 Gaz | US | RAW: Total Invalidation |
| January 4, 2013 | 2013/2 Gaz | TR | Rejection |
| January 17, 2012 | 2012/6 Gaz | CH | Rejection |
| December 23, 2011 | 2013/18 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| December 19, 2011 | 2011/51 Gaz | EM | Rejection |
| December 15, 2011 | 2013/16 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| October 3, 2011 | 2011/40 Gaz | CN | Rejection |
| July 8, 2011 | 2011/28 Gaz | AU | Rejection |
| June 16, 2011 | 2011/24 Gaz | JP | Rejection |
| June 1, 2011 | 2011/32 Gaz | MC | Rejection |
| February 9, 2011 | 2011/6 Gaz | US | Rejection |
| August 24, 2010 | 2011/3 Gaz | FR | Registration |
ID: 141063526